These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29622134)

  • 1. How Does MR Imaging Help Care for the Breast Cancer Patient? Perspective of a Medical Oncologist.
    Raghavendra AS; Tripathy D
    Magn Reson Imaging Clin N Am; 2018 May; 26(2):289-293. PubMed ID: 29622134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Does MR Imaging Help Care for My Breast Cancer Patient? Perspective of a Surgical Oncologist.
    Raber B; Bea VJ; Bedrosian I
    Magn Reson Imaging Clin N Am; 2018 May; 26(2):281-288. PubMed ID: 29622133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Does MR Imaging Help Care for My Breast Cancer Patient? Perspective of a Radiation Oncologist.
    Christopherson KM; Smith BD
    Magn Reson Imaging Clin N Am; 2018 May; 26(2):295-302. PubMed ID: 29622135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of MR Imaging for the Locoregional Staging of Breast Cancer.
    Ray KM; Hayward JH; Joe BN
    Magn Reson Imaging Clin N Am; 2018 May; 26(2):191-205. PubMed ID: 29622125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of MR Imaging in Neoadjuvant Therapy Monitoring.
    Le-Petross HT; Lim B
    Magn Reson Imaging Clin N Am; 2018 May; 26(2):207-220. PubMed ID: 29622126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Breast MR Imaging with Molecular Breast Imaging in Breast Cancer Screening, Diagnosis, Staging, and Treatment Response Evaluation.
    Rauch GM; Adrada BE
    Magn Reson Imaging Clin N Am; 2018 May; 26(2):273-280. PubMed ID: 29622132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The assessment of breast cancer response to neoadjuvant chemotherapy: comparison of magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography.
    Park JS; Moon WK; Lyou CY; Cho N; Kang KW; Chung JK
    Acta Radiol; 2011 Feb; 52(1):21-8. PubMed ID: 21498321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer staging with breast MR imaging.
    Morris EA
    Magn Reson Imaging Clin N Am; 2001 May; 9(2):333-44, vi-vii. PubMed ID: 11493423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging in breast cancer.
    Van Goethem M; Tjalma W; Schelfout K; Verslegers I; Biltjes I; Parizel P
    Eur J Surg Oncol; 2006 Nov; 32(9):901-10. PubMed ID: 16920327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging.
    Abraham DC; Jones RC; Jones SE; Cheek JH; Peters GN; Knox SM; Grant MD; Hampe DW; Savino DA; Harms SE
    Cancer; 1996 Jul; 78(1):91-100. PubMed ID: 8646731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staging of breast cancer with ultrasound.
    Yang WT
    Semin Ultrasound CT MR; 2011 Aug; 32(4):331-41. PubMed ID: 21782123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast MR imaging for extent of disease assessment in patients with newly diagnosed breast cancer.
    Brasic N; Wisner DJ; Joe BN
    Magn Reson Imaging Clin N Am; 2013 Aug; 21(3):519-32. PubMed ID: 23928242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast MR Imaging in Newly Diagnosed Breast Cancer.
    Gupta D; Billadello L
    Radiol Clin North Am; 2017 May; 55(3):541-552. PubMed ID: 28411679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast PET/MR Imaging.
    Melsaether A; Moy L
    Radiol Clin North Am; 2017 May; 55(3):579-589. PubMed ID: 28411681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging--comparison with contrast-enhanced MR imaging and pathologic findings.
    Woodhams R; Kakita S; Hata H; Iwabuchi K; Kuranami M; Gautam S; Hatabu H; Kan S; Mountford C
    Radiology; 2010 Feb; 254(2):357-66. PubMed ID: 20093508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative evaluation of residual tumor extent by three-dimensional magnetic resonance imaging in breast cancer patients treated with neoadjuvant chemotherapy.
    Akazawa K; Tamaki Y; Taguchi T; Tanji Y; Miyoshi Y; Kim SJ; Ueda S; Yanagisawa T; Sato Y; Tamura S; Noguchi S
    Breast J; 2006; 12(2):130-7. PubMed ID: 16509837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement.
    Michel SC; Keller TM; Fröhlich JM; Fink D; Caduff R; Seifert B; Marincek B; Kubik-Huch RA
    Radiology; 2002 Nov; 225(2):527-36. PubMed ID: 12409591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer.
    Orel SG; Schnall MD
    Radiology; 2001 Jul; 220(1):13-30. PubMed ID: 11425968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [MR imaging of the breast before and after neoadjuvant treatment - enhancement characteristics and T 2 signal intensity of breast cancers and breast parenchyma].
    Siegmann KC; Müller KT; Vogel U; Krauss K; Claussen CD
    Rofo; 2010 Jun; 182(6):493-500. PubMed ID: 19953430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Residual Disease With Molecular Breast Imaging in Patients Undergoing Neoadjuvant Therapy: Association With Molecular Subtypes.
    Menes TS; Golan O; Vainer G; Lerman H; Schneebaum S; Klausner J; Even-Sapir E
    Clin Breast Cancer; 2016 Oct; 16(5):389-395. PubMed ID: 27282845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.